Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The myelin mutants as models to study myelin repair in the leukodystrophies.
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway With Aging.
Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
Personalized medicine in multiple sclerosis: hope or reality?
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Fingolimod after natalizumab and the risk of short-term relapse.
Prediction of risk of fracture in the tibia due to altered bone mineral density distribution resulting from disuse: A finite element study.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene-environment interactions.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Multidisciplinary management of multiple sclerosis symptoms.
Dalfampridine prior authorization program: a cohort study.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Pages
« first
‹ previous
…
294
295
296
297
298
299
300
301
302
…
next ›
last »